Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score38
United States Fiscal year ends December CIK 0001776111 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
P. Kent Hawryluk
26 Feb 2026
President & CEO
Exercised, kept
28,768
$16.00
$460.29K
P. Kent Hawryluk
24 Oct 2025
President & CEO
Exercised, kept
182,859
$3.25
$594.29K

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 49,260,955
History held since 13 Sep 2024